Clinical Trials Logo

Clinical Trial Summary

Primary Objective: To assess the effects of SAR407899 on coronary vasomotor function using the coronary flow reserve (CFR) in participants with microvascular angina (MVA) and/or persistent stable angina despite angiographically successful percutaneous coronary intervention (PCI). Secondary Objectives: - To assess the effects of SAR407899 on quality of life using Seattle Angina Questionnaire physical limitation scale (SAQ-PL) in participants with MVA and/or persistent stable angina despite angiographically successful PCI. - To assess the safety of SAR407899 in participants with MVA and/or persistent stable angina despite angiographically successful PCI with a focus on identified risks such as hypotension and orthostatic hypotension. - To assess SAR407899 plasma concentrations in MVA participants and/or persistent stable angina despite angiographically successful PCI.


Clinical Trial Description

The total duration of study per participant was: - up to 9 weeks for participants with previous coronary artery angiography or coronary computed tomography angiography (CCTA) within 24 months prior to screening with up to 4 weeks screening period, 3 weeks titration phase, 1 week maintenance period, and 1 week follow-up after the last investigational medicinal product administration. or - up to 11 weeks for participants with previous coronary artery angiography or CCTA between 24 months and 5 years prior to screening who need CCTA during screening period with up to 6 weeks screening period, 3 weeks titration phase, 1 week maintenance period, and 1 week follow-up after the last investigational medicinal product administration. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03236311
Study type Interventional
Source Sanofi
Contact
Status Terminated
Phase Phase 2
Start date October 12, 2017
Completion date July 23, 2018

See also
  Status Clinical Trial Phase
Withdrawn NCT04069234 - Study in Diabetes Mellitus Patients Without Prior Myocardial Infarction or Stroke Undergoing Elective Percutaneous Coronary Intervention. Phase 3
Recruiting NCT04560829 - Additive Value of Physiology Coronary in Clinical Practice
Recruiting NCT06080919 - Plaque Modification And Impact On Microcirculatory Territory After Drug-Coated Balloon Percutaneous Coronary Intervention (PLAMI). N/A
Terminated NCT04614467 - A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction Phase 2
Recruiting NCT04598308 - EUROpean Coronary microCirculatory Resistance and Absolute Flow Trial
Recruiting NCT04541797 - Stress Cardiac Magnetic Resonance of Asymptomatic Type 2 Diabetics With Cardiovascular High Risk to Measure Empagliflozin Impact on Myocardial Blood Flow (CATCH-EM) N/A
Active, not recruiting NCT05197361 - Microvascular Coronary Resistance and Absolute Coronary FLOW in Patients With Percutaneous Intervention of a Chronic Total Occlusion
Recruiting NCT04827498 - Myocardial Ischemia Without Obstructive Coronary Stenoses
Suspended NCT05756088 - Determining the Association of Microvascular Disease as Assessed by PET and Graft Injury by Donor Derived Cell Free DNA
Recruiting NCT06118450 - Clinical Trial for Evaluating the Effectiveness and Safety of Online caIMR in STEMI Patients
Recruiting NCT03217227 - Evaluating Myocardial Ischemia in Chest Pain Using Exercise CMR
Completed NCT03462017 - Pharmacodynamic Study to Assess the Effects of Repeated Dosing of SAR247799 on Endothelial Function in Patients With Type 2 Diabetes Mellitus Phase 1
Not yet recruiting NCT06269874 - Study Comparing Two Administration Pathways for Adenosine During Microvascular Function Assessment N/A
Not yet recruiting NCT06217120 - Reversing Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction Phase 2/Phase 3
Recruiting NCT06316661 - CMR Assessment of Cardiac Microvascular Dysfunction in Patients With HFpEF
Recruiting NCT04131075 - The Cerebral-Coronary Connection (C3) Study
Completed NCT04485234 - Inclusive Invasive Physiological Assessment in Angina Syndromes Registry
Completed NCT05471739 - Simultaneous Assessment of Coronary Microvascular Dysfunction and Ischemia With Non-obstructed Coronary Arteries With Intracoronary Electrocardiogram and Intracoronary Doppler
Completed NCT05406297 - Impact of TMAO Serum Levels on Hyperemic IMR in STEMI Patients
Not yet recruiting NCT06069401 - The MASTER-PACT Study